P&G CFO Schulten: Growth Rebound 12 to 18 Months Out

P&G's message at the investor conference was continuity of strategy paired with operational change. CFO Andre Schulten described the approach as keeping the consumer-focused strategy while reworking execution, saying "the art in the strategy is the consistent execution." That framing comes as the company works through slower category growth, commodity costs, and higher transportation costs.

The operational details show where that effort is landing. Supply Chain 3.0 is in execution and expected to deliver productivity benefits over the next five to 10 years. R&D is using a Molecular Discovery Suite to find new molecules faster. Marketing content creation has moved fully in-house. North American focus has widened from category-country to category-customer combinations. Pricing and promotional actions have been taken in diapers, oral care, and club-channel family care.

The stakes hinge on whether those changes translate into the growth Schulten outlined. He pointed to China's five consecutive quarters of growth and share gains as evidence the approach can work, and cited Thorne as a bolt-on investment that fits P&G's beauty and health care strategy. How quickly the U.S. base solidifies before the second half, and how fast Supply Chain 3.0 scales, are likely to shape whether the 12-to-18-month target holds.